Amedeo Smart

Free Medical Literature Service


 

Amedeo

Vaccines

  Free Subscription

Articles published in
J Virol
    September 2022
  1. CHABOT S, Gimie Y, Obeid K, Kim J, et al
    Enhanced In Vitro and In Vivo Potency of a T Cell Epitope in the Ebola Virus Glycoprotein Following Amino Acid Replacement at HLA-A*02:01 Binding Positions.
    J Virol. 2022;96:e0116621.
    >> Share

  2. REDDY VRAP, Nazki S, Brodrick AJ, Asfor A, et al
    Evaluating the Breadth of Neutralizing Antibody Responses Elicited by Infectious Bursal Disease Virus Genogroup A1 Strains Using a Novel Chicken B-Cell Rescue System and Neutralization Assay.
    J Virol. 2022;96:e0125522.
    >> Share

  3. DU Q, Yang X, Ma M, Zhang Q, et al
    The gC1qR Binding Site Mutant PCV2 Is a Potential Vaccine Strain That Does Not Impair Memory CD4(+) T-Cell Generation by Vaccines.
    J Virol. 2022 Sep 19:e0095922. doi: 10.1128/jvi.00959.
    >> Share

  4. SIA ZR, Chiem K, Huang WC, Seffouh A, et al
    Respiratory Vaccination with Hemagglutinin Nanoliposomes Protects Mice from Homologous and Heterologous Strains of Influenza Virus.
    J Virol. 2022 Sep 15:e0100622. doi: 10.1128/jvi.01006.
    >> Share

  5. AO Z, Ouyang MJ, Olukitibi TA, Warner B, et al
    A Recombinant VSV-Based Bivalent Vaccine Effectively Protects against Both SARS-CoV-2 and Influenza A Virus Infection.
    J Virol. 2022 Sep 7:e0133722. doi: 10.1128/jvi.01337.
    >> Share

    August 2022
  6. SHEN W, Wang Q, Wang Z, Liu M, et al
    Specific Monoclonal Antibodies Targeting Unique HA Epitopes Block H7N9 Influenza A Viral Replication.
    J Virol. 2022 Aug 29:e0123822. doi: 10.1128/jvi.01238.
    >> Share

  7. FILES JK, Sterrett S, Henostroza S, Fucile C, et al
    HLA-II-Associated HIV-1 Adaptation Decreases CD4(+) T-Cell Responses in HIV-1 Vaccine Recipients.
    J Virol. 2022 Aug 24:e0119122. doi: 10.1128/jvi.01191.
    >> Share

  8. NEERUKONDA SN, Wang R, Vassell R, Baha H, et al
    Characterization of Entry Pathways, Species-Specific Angiotensin-Converting Enzyme 2 Residues Determining Entry, and Antibody Neutralization Evasion of Omicron BA.1, BA.1.1, BA.2, and BA.3 Variants.
    J Virol. 2022 Aug 24:e0114022. doi: 10.1128/jvi.01140.
    >> Share

  9. GUPTA SL, Mantus G, Manning KE, Ellis M, et al
    Loss of Pfizer (BNT162b2) Vaccine-Induced Antibody Responses against the SARS-CoV-2 Omicron Variant in Adolescents and Adults.
    J Virol. 2022 Aug 17:e0058222. doi: 10.1128/jvi.00582.
    >> Share

  10. KEEP S, Stevenson-Leggett P, Dowgier G, Foldes K, et al
    A Temperature-Sensitive Recombinant of Avian Coronavirus Infectious Bronchitis Virus Provides Complete Protection against Homologous Challenge.
    J Virol. 2022 Aug 16:e0110022. doi: 10.1128/jvi.01100.
    >> Share

  11. SHI J, Zheng J, Tai W, Verma AK, et al
    A Glycosylated RBD Protein Induces Enhanced Neutralizing Antibodies against Omicron and Other Variants with Improved Protection against SARS-CoV-2 Infection.
    J Virol. 2022 Aug 16:e0011822. doi: 10.1128/jvi.00118.
    >> Share

  12. VERMILLION MS, Dearing J, Zhang Y, Adney DR, et al
    Animal Models of Enterovirus D68 Infection and Disease.
    J Virol. 2022;96:e0083322.
    >> Share

  13. DODANTENNA N, Ranathunga L, Chathuranga WAG, Weerawardhana A, et al
    African Swine Fever Virus EP364R and C129R Target Cyclic GMP-AMP To Inhibit the cGAS-STING Signaling Pathway.
    J Virol. 2022;96:e0102222.
    >> Share

  14. CHAN M, Tiwary M, Wu HL, Tailor N, et al
    Pandemic 1918 Influenza Virus Does Not Cause Lethal Infection in Rhesus or Cynomolgus Macaques.
    J Virol. 2022 Aug 4:e0072822. doi: 10.1128/jvi.00728.
    >> Share

  15. ABBADI N, Nagashima K, Pena-Briseno A, Ross TM, et al
    Differential Recognition of Computationally Optimized H3 Hemagglutinin Influenza Vaccine Candidates by Human Antibodies.
    J Virol. 2022 Aug 2:e0089622. doi: 10.1128/jvi.00896.
    >> Share

  16. YUAN M, Chen X, Zhu Y, Dong X, et al
    A Bispecific Antibody Targeting RBD and S2 Potently Neutralizes SARS-CoV-2 Omicron and Other Variants of Concern.
    J Virol. 2022 Aug 2:e0077522. doi: 10.1128/jvi.00775.
    >> Share

    July 2022
  17. DING M, Dang W, Liu H, Xu F, et al
    Combinational Deletions of MGF360-9L and MGF505-7R Attenuated Highly Virulent African Swine Fever Virus and Conferred Protection against Homologous Challenge.
    J Virol. 2022;96:e0032922.
    >> Share

  18. VUONO E, Ramirez-Medina E, Silva E, Rai A, et al
    Deletion of the H108R Gene Reduces Virulence of the Pandemic Eurasia Strain of African Swine Fever Virus with Surviving Animals Being Protected against Virulent Challenge.
    J Virol. 2022;96:e0054522.
    >> Share

  19. WANG M, Bohorquez JA, Munoz-Gonzalez S, Gerber M, et al
    Removal of the E(rns) RNase Activity and of the 3' Untranslated Region Polyuridine Insertion in a Low-Virulence Classical Swine Fever Virus Triggers a Cytokine Storm and Lethal Disease.
    J Virol. 2022;96:e0043822.
    >> Share

  20. PUSNIK J, Konig J, Mai K, Richter E, et al
    Persistent Maintenance of Intermediate Memory B Cells Following SARS-CoV-2 Infection and Vaccination Recall Response.
    J Virol. 2022 Jul 12:e0076022. doi: 10.1128/jvi.00760.
    >> Share

  21. CHAPARIAN RR, Harding AT, Hamele CE, Riebe K, et al
    A Virion-Based Combination Vaccine Protects against Influenza and SARS-CoV-2 Disease in Mice.
    J Virol. 2022 Jul 12:e0068922. doi: 10.1128/jvi.00689.
    >> Share

  22. RAMIREZ-MEDINA E, Vuono E, Silva E, Rai A, et al
    Evaluation of the Deletion of MGF110-5L-6L on Swine Virulence from the Pandemic Strain of African Swine Fever Virus and Use as a DIVA Marker in Vaccine Candidate ASFV-G-DeltaI177L.
    J Virol. 2022 Jul 11:e0059722. doi: 10.1128/jvi.00597.
    >> Share

  23. VAN DE VEN K, van Dijken H, Du W, de Heij F, et al
    Varying Viral Replication and Disease Profiles of H2N2 Influenza in Ferrets Is Associated with Virus Isolate and Inoculation Route.
    J Virol. 2022 Jul 11:e0073222. doi: 10.1128/jvi.00732.
    >> Share

    June 2022
  24. VAN OOSTEN L, Yan K, Rawle DJ, Le TT, et al
    An S1-Nanoparticle Vaccine Protects against SARS-CoV-2 Challenge in K18-hACE2 Mice.
    J Virol. 2022 Jun 29:e0084422. doi: 10.1128/jvi.00844.
    >> Share

  25. SHEWARD DJ, Hermanus T, Murrell B, Garrett N, et al
    HIV Coinfection Provides Insights for the Design of Vaccine Cocktails to Elicit Broadly Neutralizing Antibodies.
    J Virol. 2022 Jun 27:e0032422. doi: 10.1128/jvi.00324.
    >> Share

  26. KIM A, Lee G, Hwang JH, Park JH, et al
    BacMam Expressing Highly Glycosylated Porcine Interferon Alpha Induces Robust Antiviral and Adjuvant Effects against Foot-and-Mouth Disease Virus in Pigs.
    J Virol. 2022;96:e0052822.
    >> Share

  27. OLCZAK P, Matsui K, Wong M, Alvarez J, et al
    RG2-VLP: a Vaccine Designed to Broadly Protect against Anogenital and Skin Human Papillomaviruses Causing Human Cancer.
    J Virol. 2022 Jun 15:e0056622. doi: 10.1128/jvi.00566.
    >> Share

  28. SUN C, Yuan RY, Xie C, Sun JF, et al
    Induction of Broadly Cross-Reactive Antibody Responses to SARS-CoV-2 Variants by S1 Nanoparticle Vaccines.
    J Virol. 2022 Jun 14:e0038322. doi: 10.1128/jvi.00383.
    >> Share

  29. LIN J, Law R, Korosec CS, Zhou C, et al
    Longitudinal Assessment of SARS-CoV-2-Specific T Cell Cytokine-Producing Responses for 1 Year Reveals Persistence of Multicytokine Proliferative Responses, with Greater Immunity Associated with Disease Severity.
    J Virol. 2022 Jun 14:e0050922. doi: 10.1128/jvi.00509.
    >> Share

  30. CHEN X, Li J, Yang L, Zhou Y, et al
    Immunoglobin G Sero-Dynamics Aided Host Specific Linear Epitope Identification and Differentiation of Infected from Vaccinated Hosts.
    J Virol. 2022 Jun 6:e0014322. doi: 10.1128/jvi.00143.
    >> Share

    May 2022
  31. PRICE GE, Lo CY, Misplon JA, Epstein SL, et al
    Reduction of Influenza A Virus Transmission in Mice by a Universal Intranasal Vaccine Candidate is Long-Lasting and Does Not Require Antibodies.
    J Virol. 2022 May 31:e0032022. doi: 10.1128/jvi.00320.
    >> Share

  32. DELVA JL, Van Waesberghe C, Van Den Broeck W, Lamote JA, et al
    The Attenuated Pseudorabies Virus Vaccine Strain Bartha Hyperactivates Plasmacytoid Dendritic Cells by Generating Large Amounts of Cell-Free Virus in Infected Epithelial Cells.
    J Virol. 2022 May 23:e0219921. doi: 10.1128/jvi.02199.
    >> Share

  33. VANDOORN E, Stadejek W, Parys A, Chepkwony S, et al
    Pathobiology of an NS1-Truncated H3N2 Swine Influenza Virus Strain in Pigs.
    J Virol. 2022 May 12:e0051922. doi: 10.1128/jvi.00519.
    >> Share

  34. LINVILLE AC, Rico AB, Teague H, Binsted LE, et al
    Dysregulation of Cellular VRK1, BAF, and Innate Immune Signaling by the Vaccinia Virus B12 Pseudokinase.
    J Virol. 2022 May 11:e0039822. doi: 10.1128/jvi.00398.
    >> Share

  35. LUCAS CJ, Davenport BJ, Carpentier KS, Tinega AN, et al
    Two Conserved Phenylalanine Residues in the E1 Fusion Loop of Alphaviruses Are Essential for Viral Infectivity.
    J Virol. 2022;96:e0006422.
    >> Share

  36. TU JJ, Kumar A, Giorgi EE, Eudailey J, et al
    Vertical HIV-1 Transmission in the Setting of Maternal Broad and Potent Antibody Responses.
    J Virol. 2022 May 10:e0023122. doi: 10.1128/jvi.00231.
    >> Share

    April 2022
  37. MANTLO EK, Maruyama J, Manning JT, Wanninger TG, et al
    Machupo Virus with Mutations in the Transmembrane Domain and Glycosylation Sites of the Glycoprotein Is Attenuated and Immunogenic in Animal Models of Bolivian Hemorrhagic Fever.
    J Virol. 2022;96:e0020922.
    >> Share

  38. KIRKPATRICK ROUBIDOUX E, Sano K, McMahon M, Carreno JM, et al
    Novel Epitopes of the Influenza Virus N1 Neuraminidase Targeted by Human Monoclonal Antibodies.
    J Virol. 2022 Apr 21:e0033222. doi: 10.1128/jvi.00332.
    >> Share

  39. NUNEZ CASTREJON AM, O'Rourke SM, Kauvar LM, DuBois RM, et al
    Structure-Based Design and Antigenic Validation of Respiratory Syncytial Virus G Immunogens.
    J Virol. 2022;96:e0220121.
    >> Share

  40. DESCHAMBAULT Y, Lynch J, Warner B, Tierney K, et al
    Single Immunization with Recombinant ACAM2000 Vaccinia Viruses Expressing the Spike and the Nucleocapsid Proteins Protects Hamsters against SARS-CoV-2-Caused Clinical Disease.
    J Virol. 2022 Apr 12:e0038922. doi: 10.1128/jvi.00389.
    >> Share

  41. TEMPLETON CW, Traktman P
    UV Irradiation of Vaccinia Virus-Infected Cells Impairs Cellular Functions, Introduces Lesions into the Viral Genome, and Uncovers Repair Capabilities for the Viral Replication Machinery.
    J Virol. 2022 Apr 11:e0213721. doi: 10.1128/jvi.02137.
    >> Share

  42. KONG XW, Zhang X, Bu GL, Xu HQ, et al
    Vesicular Stomatitis Virus-Based Epstein-Barr Virus Vaccines Elicit Strong Protective Immune Responses.
    J Virol. 2022 Apr 11:e0033622. doi: 10.1128/jvi.00336.
    >> Share

  43. BRIGGS K, Kirby C, Beavis AC, Zengel J, et al
    Immunogenicity of Mumps Virus Genotype G Vaccine Candidates in Jeryl Lynn-Immunized Mice.
    J Virol. 2022 Apr 7:e0198321. doi: 10.1128/jvi.01983.
    >> Share

  44. FARIAS JP, da Silva PS, Fogaca MMC, Santana IVR, et al
    The COVID-19 Humoral Immunological Status Induced by CoronaVac and AstraZeneca Vaccines Significantly Benefits from a Booster Shot with the Pfizer Vaccine.
    J Virol. 2022 Apr 7:e0017722. doi: 10.1128/jvi.00177.
    >> Share

  45. KLASSE PJ, Moore JP
    Reappraising the Value of HIV-1 Vaccine Correlates of Protection Analyses.
    J Virol. 2022 Apr 6:e0003422. doi: 10.1128/jvi.00034.
    >> Share

    March 2022
  46. LIU MQ, Jiang RD, Guo J, Chen Y, et al
    Inactivated SARS-CoV-2 Vaccine Shows Cross-Protection against Bat SARS-Related Coronaviruses in Human ACE2 Transgenic Mice.
    J Virol. 2022 Mar 28:e0016922. doi: 10.1128/jvi.00169.
    >> Share

  47. NGUYEN HT, Qualizza A, Anang S, Zhao M, et al
    Functional and Highly Cross-Linkable HIV-1 Envelope Glycoproteins Enriched in a Pretriggered Conformation.
    J Virol. 2022 Mar 28:e0166821. doi: 10.1128/jvi.01668.
    >> Share

  48. EICHHOLZ K, Tran TH, Cheneau C, Tran TTP, et al
    Adenovirus-alpha-Defensin Complexes Induce NLRP3-Associated Maturation of Human Phagocytes via Toll-Like Receptor 4 Engagement.
    J Virol. 2022;96:e0185021.
    >> Share

  49. RATHAKRISHNAN A, Connell S, Petrovan V, Moffat K, et al
    Differential Effect of Deleting Members of African Swine Fever Virus Multigene Families 360 and 505 from the Genotype II Georgia 2007/1 Isolate on Virus Replication, Virulence, and Induction of Protection.
    J Virol. 2022;96:e0189921.
    >> Share

  50. CHEN SMY, Wong YC, Yim LY, Zhang H, et al
    Enhanced Cross-Reactive and Polyfunctional Effector-Memory T Cell Responses by ICVAX-a Human PD1-Based Bivalent HIV-1 Gag-p41 Mosaic DNA Vaccine.
    J Virol. 2022 Mar 17:e0216121. doi: 10.1128/jvi.02161.
    >> Share

  51. ALLEN JD, Ross TM
    Bivalent H1 and H3 COBRA Recombinant Hemagglutinin Vaccines Elicit Seroprotective Antibodies against H1N1 and H3N2 Influenza Viruses from 2009 to 2019.
    J Virol. 2022 Mar 15:e0165221. doi: 10.1128/jvi.01652.
    >> Share

    February 2022
  52. ELSAYED H, Nabi G, McKinstry WJ, Khoo KK, et al
    Correction for Elsayed et al., "Intrastructural Help: Harnessing T Helper Cells Induced by Licensed Vaccines for Improvement of HIV Env Antibody Responses to Virus-Like Particle Vaccines".
    J Virol. 2022;96:e0195421.
    >> Share

  53. UTRILLA-TRIGO S, Jimenez-Cabello L, Calvo-Pinilla E, Marin-Lopez A, et al
    The Combined Expression of the Nonstructural Protein NS1 and the N-Terminal Half of NS2 (NS21-180) by ChAdOx1 and MVA Confers Protection against Clinical Disease in Sheep upon Bluetongue Virus Challenge.
    J Virol. 2022;96:e0161421.
    >> Share

  54. ZHANG YN, Zhang ZR, Li N, Pei XR, et al
    High titer self-propagating capsidless Chikungunya virus generated in Vero cells as a strategy for alphavirus vaccine development.
    J Virol. 2022 Feb 2:JVI0148021. doi: 10.1128/JVI.01480.
    >> Share

  55. ROSU ME, Kok A, Bestebroer TM, de Meulder D, et al
    Contribution of neuraminidase to the efficacy of seasonal split influenza vaccines in the ferret model.
    J Virol. 2022 Feb 2:jvi0195921. doi: 10.1128/jvi.01959.
    >> Share

    January 2022
  56. LI Y, Yuan M, Han Y, Xie L, et al
    The Unique Glycosylation at Position 986 on the E2 Glycoprotein of Classical Swine Fever Virus Is Responsible for Viral Attenuation and Protection against Lethal Challenge.
    J Virol. 2022;96:e0176821.
    >> Share

  57. GMYREK GB, Predki P, Gershburg E, Carr DJJ, et al
    Noncognate Signals Drive Enhanced Effector CD8(+) T Cell Responses through an IFNAR1-Dependent Pathway after Infection with the Prototypic Vaccine, 0DeltaNLS, against Herpes Simplex Virus 1.
    J Virol. 2022 Jan 19:JVI0172421. doi: 10.1128/JVI.01724.
    >> Share

  58. KEEP S, Stevenson-Leggett P, Dowgier G, Everest H, et al
    Identification of amino acids within non-structural proteins 10 and 14 of the avian coronavirus infectious bronchitis virus that result in attenuation in vivo and in ovo.
    J Virol. 2022 Jan 19:jvi0205921. doi: 10.1128/jvi.02059.
    >> Share

  59. PETROVAN V, Rathakrishnan A, Islam M, Goatley LC, et al
    Role of African Swine Fever Virus Proteins EP153R and EP402R in Reducing Viral Persistence in Blood and Virulence in Pigs Infected with BeninDeltaDP148R.
    J Virol. 2022;96:e0134021.
    >> Share

  60. KIMBLE JB, Wymore Brand M, Kaplan BS, Gauger P, et al
    Vaccine-associated enhanced respiratory disease following influenza virus infection in ferrets recapitulates the model in pigs.
    J Virol. 2022 Jan 5:JVI0172521. doi: 10.1128/JVI.01725.
    >> Share

  61. MCGREGOR J, Hardy JM, Lay CS, Boo I, et al
    Virus-Like Particles Containing the E2 Core Domain of Hepatitis C Virus Generate Broadly Neutralizing Antibodies in Guinea Pigs.
    J Virol. 2022 Jan 5:JVI0167521. doi: 10.1128/JVI.01675.
    >> Share

    December 2021
  62. HUANG Y, Skarlupka AL, Jang H, Blas-Machado U, et al
    SARS-CoV-2 and Influenza A virus Co-infections in Ferrets.
    J Virol. 2021 Dec 22:JVI0179121. doi: 10.1128/JVI.01791.
    >> Share

  63. CAO K, Wang X, Peng H, Ding L, et al
    A Single Vaccine Protects against SARS-CoV-2 and Influenza Virus in Mice.
    J Virol. 2021 Dec 15:JVI0157821. doi: 10.1128/JVI.01578.
    >> Share

  64. MUCKER EM, Golden JW, Hammerbeck CD, Kishimori JM, et al
    A nucleic acid-based orthopoxvirus vaccine targeting the vaccinia virus L1, A27, B5 and A33 proteins protects rabbits against lethal rabbitpox virus aerosol challenge.
    J Virol. 2021 Dec 1:JVI0150421. doi: 10.1128/JVI.01504.
    >> Share

    November 2021
  65. WU C, He Y, Zhao J, Luo K, et al
    Exacerbated AIDS progression by PD-1 blockade during therapeutic vaccination in chronically SIV-infected rhesus macaques after ART treatment interruption.
    J Virol. 2021 Nov 24:JVI0178521. doi: 10.1128/JVI.01785.
    >> Share

  66. APPELBERG S, John L, Pardi N, Vegvari A, et al
    Nucleoside-modified mRNA vaccines protect IFNAR(-/-) mice against Crimean Congo hemorrhagic fever virus infection.
    J Virol. 2021 Nov 24:JVI0156821. doi: 10.1128/JVI.01568.
    >> Share

  67. BURCKHARDT RM, Dennehy JJ, Poon LLM, Saif LJ, et al
    Are COVID-19 Vaccine Boosters Needed? The Science behind Boosters.
    J Virol. 2021 Nov 24:JVI0197321. doi: 10.1128/JVI.01973.
    >> Share

  68. ZHANG H, Zheng H, Guo P, Hu L, et al
    Correction for Zhang et al., "Broadly Protective CD8(+) T Cell Immunity to Highly Conserved Epitopes Elicited by Heat Shock Protein gp96-Adjuvanted Influenza Monovalent Split Vaccine".
    J Virol. 2021;95:e0175021.
    >> Share

  69. SOUZA CK, Anderson TK, Chang J, Venkatesh D, et al
    Antigenic distance between North American swine and human seasonal H3N2 influenza A viruses as an indication of zoonotic risk to humans.
    J Virol. 2021 Nov 10:JVI0137421. doi: 10.1128/JVI.01374.
    >> Share

  70. VANBLARGAN LA, Milutinovic PS, Goo L, DeMaso CR, et al
    Dengue Virus Serotype 1 Conformational Dynamics Confers Virus Strain-Dependent Patterns of Neutralization by Polyclonal Sera.
    J Virol. 2021;95:e0095621.
    >> Share

  71. ZHANG Y, Ke J, Zhang J, Yang J, et al
    African Swine Fever Virus Bearing an I226R Gene Deletion Elicits Robust Immunity in Pigs to African Swine Fever.
    J Virol. 2021;95:e0119921.
    >> Share

  72. MIELKE D, Stanfield-Oakley S, Borate B, Fisher LH, et al
    Selection of HIV Envelope strains for standardized assessments of vaccine-elicited antibody-dependent cellular cytotoxicity (ADCC)-mediating antibodies.
    J Virol. 2021 Nov 3:JVI0164321. doi: 10.1128/JVI.01643.
    >> Share

  73. CARTEN JD, Greseth M, Traktman P
    Structure-function analysis of two interacting vaccinia proteins that are critical for viral morphogenesis: L2 and A30.5.
    J Virol. 2021 Nov 3:JVI0157721. doi: 10.1128/JVI.01577.
    >> Share

    October 2021
  74. YU J, Collins ND, Mercado NB, McMahan K, et al
    Protective Efficacy of Gastrointestinal SARS-CoV-2 Delivery Against Intranasal and Intratracheal SARS-CoV-2 Challenge in Rhesus Macaques.
    J Virol. 2021 Oct 27:JVI0159921. doi: 10.1128/JVI.01599.
    >> Share

  75. SCHORCHT A, Cottrell CA, Pugach P, Ringe RP, et al
    The glycan hole area of HIV-1 envelope trimers contributes prominently to the induction of autologous neutralization.
    J Virol. 2021 Oct 20:JVI0155221. doi: 10.1128/JVI.01552.
    >> Share

  76. BELTRAN-PAVEZ C, Bontjer I, Gonzalez N, Pernas M, et al
    Potent Induction of Envelope-Specific Antibody Responses by Virus-Like Particle (VLP) Immunogens Based on HIV-1 Envelopes from Patients with Early Broadly Neutralizing Responses.
    J Virol. 2021 Oct 20:JVI0134321. doi: 10.1128/JVI.01343.
    >> Share

  77. GLADUE DP, Ramirez-Medina E, Vuono E, Silva E, et al
    Deletion of the A137R Gene from the Pandemic Strain of African Swine Fever Virus Attenuates the Strain and Offers Protection against the Virulent Pandemic Virus.
    J Virol. 2021;95:e0113921.
    >> Share

  78. GAO J, Klenow L, Parsons L, Malik T, et al
    Design of the Recombinant Influenza Neuraminidase Antigen is Crucial for its Biochemical Properties and Protective Efficacy.
    J Virol. 2021 Oct 6:JVI0116021. doi: 10.1128/JVI.01160.
    >> Share

  79. CHEN C, Zhang C, Li H, Wang Z, et al
    TLR4 regulates rabies virus-induced humoral immunity through recruitment of cDC2 to lymph organs.
    J Virol. 2021 Oct 6:JVI0082921. doi: 10.1128/JVI.00829.
    >> Share

    September 2021
  80. SIEGERS JY, Dhanasekaran V, Xie R, Deng YM, et al
    Genetic and Antigenic Characterization of an Influenza A(H3N2) Outbreak in Cambodia and the Greater Mekong Subregion during the COVID-19 Pandemic, 2020.
    J Virol. 2021 Sep 29:JVI0126721. doi: 10.1128/JVI.01267.
    >> Share

  81. CHOI A, Koch M, Wu K, Dixon G, et al
    Serum Neutralizing Activity of mRNA-1273 Against SARS-CoV-2 Variants.
    J Virol. 2021 Sep 22:JVI0131321. doi: 10.1128/JVI.01313.
    >> Share

  82. TOSTANOSKI LH, Gralinski LE, Martinez DR, Schaefer A, et al
    Protective efficacy of rhesus adenovirus COVID-19 vaccines against mouse-adapted SARS-CoV-2.
    J Virol. 2021 Sep 15:JVI0097421. doi: 10.1128/JVI.00974.
    >> Share

  83. KIRCHENBAUM GA, Sautto GA, Richardson RA, Ecker JW, et al
    A competitive hemagglutination inhibition assay for dissecting functional antibody activity to influenza virus.
    J Virol. 2021 Sep 15:JVI0237920. doi: 10.1128/JVI.02379.
    >> Share

  84. WANG Z, Yuan Y, Chen C, Zhang C, et al
    Colloidal manganese salt improves the efficacy of rabies vaccines in mice, cats, and dogs.
    J Virol. 2021 Sep 8:JVI0141421. doi: 10.1128/JVI.01414.
    >> Share

  85. ZHONG C, Liu F, Hajnik RJ, Yao L, et al
    Type-I IFN promotes humoral immunity in viral vector vaccination.
    J Virol. 2021 Sep 8:JVI0092521. doi: 10.1128/JVI.00925.
    >> Share

  86. BALLMANN MZ, Raus S, Engelhart R, Kajan GL, et al
    Human AdV-20-42-42, a promising novel adenoviral vector for gene therapy and vaccine product development.
    J Virol. 2021 Sep 1:JVI0038721. doi: 10.1128/JVI.00387.
    >> Share

  87. ABRAHAM M, Beavis AC, Xiao P, Villinger FJ, et al
    Evaluation of a new viral vaccine vector in mice and rhesus macaques: J paramyxovirus (JPV)-expressing HA of influenza A virus H5N1.
    J Virol. 2021 Sep 1:JVI0132121. doi: 10.1128/JVI.01321.
    >> Share

  88. WILLIAMS CM, Roy S, Califano D, McKenzie ANJ, et al
    IL-33-ILC2 axis represents a potential adjuvant target to increase the cross-protective efficacy of influenza vaccine.
    J Virol. 2021 Sep 1:JVI0059821. doi: 10.1128/JVI.00598.
    >> Share

    August 2021
  89. FARRELL HE, Bruce K, Stevenson PG
    A live olfactory MCMV vaccine attenuated for systemic spread, protects against superinfection.
    J Virol. 2021 Aug 25:JVI0126421. doi: 10.1128/JVI.01264.
    >> Share

  90. KAWAI A, Yamamoto Y, Nogimori T, Takeshita K, et al
    The potential of neuraminidase as an antigen for nasal vaccines to increase cross-protection against influenza viruses.
    J Virol. 2021 Aug 11:JVI0118021. doi: 10.1128/JVI.01180.
    >> Share

  91. LU M, Zhang Y, Dravid P, Li A, et al
    A methyltransferase-defective VSV-based SARS-CoV-2 vaccine candidate provides complete protection against SARS-CoV-2 infection in hamsters.
    J Virol. 2021 Aug 11:JVI0059221. doi: 10.1128/JVI.00592.
    >> Share

  92. ZHANG C, Tian Y, Chen C, Wang Z, et al
    Virus-like vesicles based on SFV-containing rabies virus glycoprotein make a safe and efficacious rabies vaccine candidate in a mouse model.
    J Virol. 2021 Aug 4:JVI0079021. doi: 10.1128/JVI.00790.
    >> Share

    July 2021
  93. DONG H, Lu Y, Zhang Y, Mu S, et al
    A Heat-Induced Mutation on VP1 of Foot-and-Mouth Disease Virus Serotype O Enhanced Capsid Stability and Immunogenicity.
    J Virol. 2021;95:e0017721.
    >> Share

  94. EREZ N, Wyatt LS, Americo JL, Xiao W, et al
    Spontaneous and targeted mutations in the decapping enzyme enhance replication of modified vaccinia virus Ankara (MVA) in monkey cells.
    J Virol. 2021 Jul 7:JVI0110421. doi: 10.1128/JVI.01104.
    >> Share

    June 2021
  95. SKARLUPKA AL, Bebin-Blackwell AG, Sumner SF, Ross TM, et al
    Universal influenza virus neuraminidase vaccine elicits protective immune responses against human seasonal and pre-pandemic strains.
    J Virol. 2021 Jun 23:JVI0075921. doi: 10.1128/JVI.00759.
    >> Share

  96. SILVAS JA, Morales Vasquez D, Park JG, Chiem K, et al
    Contribution of SARS-CoV-2 accessory proteins to viral pathogenicity in K18 hACE2 transgenic mice.
    J Virol. 2021 Jun 16:JVI0040221. doi: 10.1128/JVI.00402.
    >> Share

  97. QIN Y, Tu K, Teng Q, Feng D, et al
    Identification of novel T-cell epitopes on infectious bronchitis virus N protein and development of a multi-epitope vaccine.
    J Virol. 2021 Jun 9:JVI0066721. doi: 10.1128/JVI.00667.
    >> Share

  98. QIN K, Boppana S, Carlson JM, Fiore-Gartland A, et al
    Elevated HIV infection of CD4 T cells in MRKAd5 vaccine recipients due to CD8 T cells targeting of adapted epitopes.
    J Virol. 2021 Jun 2:JVI0016021. doi: 10.1128/JVI.00160.
    >> Share

  99. NELSON SA, Dileepan T, Rasley A, Jenkins MK, et al
    Intranasal nanoparticle vaccination elicits a persistent, polyfunctional CD4 T cell response in the murine lung specific for a highly conserved influenza antigen that are sufficient to mediate protection from influenza virus challenge.
    J Virol. 2021 Jun 2:JVI0084121. doi: 10.1128/JVI.00841.
    >> Share

  100. VAN HAAREN MM, McCoy LE, Torres JL, Lee W, et al
    Antibodies from rabbits immunized with HIV-1 clade B SOSIP trimers can neutralize multiple clade B viruses by destabilizing the envelope glycoprotein.
    J Virol. 2021 Jun 2:JVI0009421. doi: 10.1128/JVI.00094.
    >> Share

    May 2021
  101. AO Z, Wang L, Azizi H, Abiola TO, et al
    Development and Evaluation of an Ebola Virus Glycoprotein Mucin-Like Domain Replacement System as a New DC-Targeting Vaccine Approach Against HIV-1.
    J Virol. 2021 May 19. pii: JVI.02368-20. doi: 10.1128/JVI.02368.
    >> Share

  102. CARNELL GW, Ciazynska KA, Wells DA, Xiong X, et al
    SARS-CoV-2 spike protein stabilized in the closed state induces potent neutralizing responses.
    J Virol. 2021 May 7. pii: JVI.00203-21. doi: 10.1128/JVI.00203.
    >> Share

  103. LEE W, Kingstad-Bakke B, Kedl RM, Kawaoka Y, et al
    CCR2 Regulates Vaccine-Induced Mucosal T-Cell Memory to Influenza A Virus.
    J Virol. 2021 May 5. pii: JVI.00530-21. doi: 10.1128/JVI.00530.
    >> Share

  104. BORCA MV, Rai A, Ramirez-Medina E, Silva E, et al
    A cell culture-adapted vaccine virus against the current pandemic African swine fever virus strain.
    J Virol. 2021 May 5. pii: JVI.00123-21. doi: 10.1128/JVI.00123.
    >> Share

  105. GOWEN BB, Hickerson BT, York J, Westover JB, et al
    Second-generation live-attenuated Candid#1 vaccine virus resists reversion and protects against lethal Junin virus infection in guinea pigs.
    J Virol. 2021 May 5. pii: JVI.00397-21. doi: 10.1128/JVI.00397.
    >> Share

    April 2021
  106. YE X, Liu X, Shu T, Deng W, et al
    A Live-attenuated Zika Virus Vaccine with High Production Capacity Confers Effective Protection in Neonatal Mice.
    J Virol. 2021 Apr 28. pii: JVI.00383-21. doi: 10.1128/JVI.00383.
    >> Share

  107. VALLEE G, Norris P, Paszkowski P, Noyce R, et al
    Vaccinia virus gene acquisition through non-homologous recombination.
    J Virol. 2021 Apr 28. pii: JVI.00318-21. doi: 10.1128/JVI.00318.
    >> Share

  108. CASTRO IM, Ricciardi MJ, Gonzalez-Nieto L, Rakasz EG, et al
    Recombinant Herpesvirus Vectors: Durable Immune Responses and Durable Protection Against SIVmac239 Acquisition
    J Virol. 2021 Apr 28. pii: JVI.00330-21. doi: 10.1128/JVI.00330.
    >> Share

  109. LEAMAN DP, Stano A, Chen Y, Zhang L, et al
    Membrane Env liposomes facilitate immunization with multivalent full-length HIV spikes.
    J Virol. 2021 Apr 21. pii: JVI.00005-21. doi: 10.1128/JVI.00005.
    >> Share

  110. SAUTTO GA, Ecker JW, Ross TM
    An H1N1 Computationally Optimized Broadly Reactive Antigen elicits a neutralizing antibody response against an emerging human-infecting Eurasian avian-like swine influenza virus.
    J Virol. 2021 Apr 14. pii: JVI.02421-20. doi: 10.1128/JVI.02421.
    >> Share

  111. MORI K, Ohniwa RL, Takizawa N, Naito T, et al
    Development of a Genetically Stable Live Attenuated Influenza Vaccine Strain using an Engineered High-Fidelity Viral Polymerase.
    J Virol. 2021 Apr 7. pii: JVI.00493-21. doi: 10.1128/JVI.00493.
    >> Share

  112. HUANG X, Ma Y, Wang Y, Niu C, et al
    Oral probiotics vaccine expressing koi herpesvirus (KHV) ORF81 protein delivered by chitosan-alginate capsules is a promising strategy for mass oral vaccination of carps against KHV infection.
    J Virol. 2021 Apr 7. pii: JVI.00415-21. doi: 10.1128/JVI.00415.
    >> Share

  113. ZHANG H, Zheng H, Guo P, Hu L, et al
    Broadly protective CD8(+) T cell immunity to highly conserved epitopes elicited by heat shock protein gp96-adjuvanted influenza monovalent split vaccine.
    J Virol. 2021 Apr 7. pii: JVI.00507-21. doi: 10.1128/JVI.00507.
    >> Share

  114. PATEL DR, Field CJ, Septer KM, Sim DG, et al
    Transmission and protection against re-infection in the ferret model with the SARS-CoV-2 USA-WA1/2020 reference isolate.
    J Virol. 2021 Apr 7. pii: JVI.02232-20. doi: 10.1128/JVI.02232.
    >> Share

    March 2021
  115. WANG J, Shu T, Deng W, Zheng Y, et al
    Mucosal priming with a recombinant influenza A virus-vectored vaccine elicits T-cell and antibody responses to HIV-1 in mice.
    J Virol. 2021 Mar 31. pii: JVI.00059-21. doi: 10.1128/JVI.00059.
    >> Share

  116. WOLLNER CJ, Richner M, Hassert MA, Pinto AK, et al
    A Dengue Virus Serotype 1 mRNA-LNP Vaccine Elicits Protective Immune Responses.
    J Virol. 2021 Mar 24. pii: JVI.02482-20. doi: 10.1128/JVI.02482.
    >> Share

  117. SCHMID DS, Miao C, Leung J, Johnson M, et al
    Comparative antibody responses to the live-attenuated and recombinant herpes zoster vaccines.
    J Virol. 2021 Mar 24. pii: JVI.00240-21. doi: 10.1128/JVI.00240.
    >> Share

  118. MA J, Su D, Sun Y, Huang X, et al
    Cryo-EM structure of S-Trimer, a subunit vaccine candidate for COVID-19.
    J Virol. 2021 Mar 10. pii: JVI.00194-21. doi: 10.1128/JVI.00194.
    >> Share

  119. JACOB-DOLAN C, Feldman J, McMahan K, Yu J, et al
    Coronavirus-Specific Antibody Cross Reactivity in Rhesus Macaques Following SARS-CoV-2 Vaccination and Infection.
    J Virol. 2021 Mar 10. pii: JVI.00117-21. doi: 10.1128/JVI.00117.
    >> Share

  120. LUO Z, Girton AW, Heaton BE, Heaton NS, et al
    Engineered influenza virions reveal the contributions of non-hemagglutinin structural proteins to vaccine mediated protection.
    J Virol. 2021 Mar 3. pii: JVI.02021-20. doi: 10.1128/JVI.02021.
    >> Share

    February 2021
  121. DHAKAL S, Loube J, Misplon JA, Lo CY, et al
    Effect of an adenovirus-vectored universal influenza virus vaccine on pulmonary pathophysiology in a mouse model.
    J Virol. 2021 Feb 24. pii: JVI.02359-20. doi: 10.1128/JVI.02359.
    >> Share

  122. BINJAWADAGI B, Ma Y, Binjawadagi R, Brakel K, et al
    Mucosal Delivery of Recombinant Vesicular Stomatitis Virus Vectors Expressing Envelope Proteins of Respiratory Syncytial Virus Induces Protective Immunity in Cotton Rats.
    J Virol. 2021;95.
    >> Share

  123. LEVY Y, Lacabaratz C, Lhomme E, Wiedemann A, et al
    A randomized placebo-controlled efficacy study of a prime boost therapeutic vaccination strategy in HIV-1 infected individuals: VRI02 ANRS 149 LIGHT Phase II trial.
    J Virol. 2021 Feb 10. pii: JVI.02165-20. doi: 10.1128/JVI.02165.
    >> Share

    January 2021
  124. TAK AI, Americo JL, Diesterbeck US, Moss B, et al
    Loss of the vaccinia virus 35-amino acid hydrophobic O3 protein is partially compensated by mutations in the transmembrane domains of other entry proteins.
    J Virol. 2021 Jan 27. pii: JVI.02228-20. doi: 10.1128/JVI.02228.
    >> Share

  125. DOMINGO E, Perales C
    The time for COVID-19 vaccination.
    J Virol. 2021 Jan 19. pii: JVI.02437-20. doi: 10.1128/JVI.02437.
    >> Share

  126. SANGARE K, Tuero I, Rahman MA, Hoang T, et al
    The immunological impact of adenovirus early genes on vaccine-induced responses in mice and nonhuman primates.
    J Virol. 2021 Jan 13. pii: JVI.02253-20. doi: 10.1128/JVI.02253.
    >> Share

  127. RICO AB, Linville AC, Olson AT, Wang Z, et al
    The Vaccinia Virus B12 Pseudokinase Represses Viral Replication via Interaction with the Cellular Kinase VRK1 and Activation of the Antiviral Effector BAF.
    J Virol. 2021;95.
    >> Share

  128. SHI Y, Shi J, Sun L, Tan Y, et al
    Insight into vaccine development for Alpha-coronaviruses based on structural and immunological analyses of spike proteins.
    J Virol. 2021 Jan 7. pii: JVI.02284-20. doi: 10.1128/JVI.02284.
    >> Share

  129. GARCIA-ARRIAZA J, Garaigorta U, Perez P, Lazaro-Frias A, et al
    COVID-19 vaccine candidates based on modified vaccinia virus Ankara expressing the SARS-CoV-2 spike induce robust T- and B-cell immune responses and full efficacy in mice.
    J Virol. 2021 Jan 7. pii: JVI.02260-20. doi: 10.1128/JVI.02260.
    >> Share

  130. JIN WP, Lu J, Zhang XY, Wu J, et al
    Efficacy of Coxsackievirus A5 Vaccine Candidates in an Actively Immunized Mouse Model.
    J Virol. 2021 Jan 6. pii: JVI.01743-20. doi: 10.1128/JVI.01743.
    >> Share

    December 2020
  131. EVERETT HE, van Diemen PM, Aramouni M, Ramsay A, et al
    Vaccines That Reduce Viral Shedding Do Not Prevent Transmission of H1N1 Pandemic 2009 Swine Influenza a Virus Infection to Unvaccinated Pigs.
    J Virol. 2020 Dec 2. pii: JVI.01787-20. doi: 10.1128/JVI.01787.
    >> Share

    November 2020
  132. UNO N, Ross TM
    A Universal Dengue Vaccine Elicits Neutralizing Antibodies Against Strains from All Four Dengue Serotypes.
    J Virol. 2020 Nov 18. pii: JVI.00658-20. doi: 10.1128/JVI.00658.
    >> Share

  133. JENKINS T, Wang R, Harder O, Xue M, et al
    A novel live attenuated RSV vaccine candidate with mutations in the L protein SAM binding site and the G protein cleavage site is protective in cotton rats and a rhesus macaque.
    J Virol. 2020 Nov 11. pii: JVI.01568-20. doi: 10.1128/JVI.01568.
    >> Share

  134. TIAN X, Landreth S, Lu Y, Pandey K, et al
    A Replication-Defective Influenza Virus Harboring H5 and H7 Hemagglutinins Provides Protection against H5N1 and H7N9 Infection in Mice.
    J Virol. 2020 Nov 11. pii: JVI.02154-20. doi: 10.1128/JVI.02154.
    >> Share

    October 2020
  135. GHORBANI A, Abundo MC, Ji H, Taylor KJM, et al
    Viral Subpopulation Screening Guides in Designing a High Interferon Inducing Live Attenuated Influenza Vaccine by Targeting Rare Mutations in NS1 and PB2 Proteins.
    J Virol. 2020 Oct 28. pii: JVI.01722-20. doi: 10.1128/JVI.01722.
    >> Share

  136. RENEER ZB, Jamieson PJ, Skarlupka AL, Huang Y, et al
    Computationally Optimized Broadly Reactive H2 HA Influenza Vaccines Elicited Broadly Cross-Reactive Antibodies and Protected Mice from Viral Challenges.
    J Virol. 2020 Oct 28. pii: JVI.01526-20. doi: 10.1128/JVI.01526.
    >> Share

  137. LIANG B, Matsuoka Y, Le Nouen C, Liu X, et al
    A parainfluenza virus vector expressing the respiratory syncytial virus (RSV) prefusion F protein is more effective than RSV for boosting a primary immunization with RSV.
    J Virol. 2020 Oct 28. pii: JVI.01512-20. doi: 10.1128/JVI.01512.
    >> Share

  138. ELENA GOMEZ C, Perdiguero B, Falqui M, Quiros M, et al
    Enhancement of HIV-1 Env-specific CD8 T cell responses using IFN-Stimulated Gene 15 (ISG15) as an immune adjuvant.
    J Virol. 2020 Oct 28. pii: JVI.01155-20. doi: 10.1128/JVI.01155.
    >> Share

  139. KANAI Y, Onishi M, Kawagishi T, Pannacha P, et al
    Reverse genetics approach for developing rotavirus vaccine candidates carrying VP4 and VP7 genes cloned from clinical isolates of human rotavirus.
    J Virol. 2020 Oct 21. pii: JVI.01374-20. doi: 10.1128/JVI.01374.
    >> Share

  140. KATO S, Shida H, Okamura T, Zhang X, et al
    CD8 T Cells Show Protection against Highly Pathogenic Simian Immunodeficiency Virus (SIV) after Vaccination with SIV Gene-Expressing BCG Prime and Vaccinia Virus/Sendai Virus Vector Boosts.
    J Virol. 2020 Oct 21. pii: JVI.01718-20. doi: 10.1128/JVI.01718.
    >> Share

  141. DEVASUNDARAM S, Rosati M, Valentin A, Weiss S, et al
    Priming with DNA expressing trimeric HIV V1V2 alters the immune hierarchy favoring the development of V2-specific antibodies in rhesus macaques.
    J Virol. 2020 Oct 21. pii: JVI.01193-20. doi: 10.1128/JVI.01193.
    >> Share

  142. MARTINS MA, Gonzalez-Nieto L, Ricciardi MJ, Bailey VK, et al
    Rectal Acquisition of SIVmac239 Infection Despite Vaccine-Induced Immune Responses Against the Entire SIV Proteome.
    J Virol. 2020 Oct 7. pii: JVI.00979-20. doi: 10.1128/JVI.00979.
    >> Share

  143. BAGRI P, Ghasemi R, McGrath JJC, Thayaparan D, et al
    Estradiol enhances anti-viral CD4(+) tissue-resident memory T cell responses following mucosal herpes simplex virus 2 vaccination through an IL-17-mediated pathway.
    J Virol. 2020 Oct 7. pii: JVI.01206-20. doi: 10.1128/JVI.01206.
    >> Share

  144. DE LORENZO G, Tandavanitj R, Doig J, Setthapramote C, et al
    Zika virus-like particles bearing covalent dimer of envelope protein protect mice from lethal challenge.
    J Virol. 2020 Oct 7. pii: JVI.01415-20. doi: 10.1128/JVI.01415.
    >> Share

    September 2020
  145. CRIADO MF, Sa E Silva M, Lee DH, de Lima Salge CA, et al
    Cross-protection by inactivated H5 pre-pandemic vaccine seed strains against diverse Goose/Guangdong lineage H5N1 highly pathogenic avian influenza viruses.
    J Virol. 2020 Sep 30. pii: JVI.00720-20. doi: 10.1128/JVI.00720.
    >> Share

  146. VOIC H, de Vries RD, Sidney J, Rubiro P, et al
    Identification and characterization of CD4+ T cell epitopes after Shingrix vaccination.
    J Virol. 2020 Sep 30. pii: JVI.01641-20. doi: 10.1128/JVI.01641.
    >> Share

  147. XUE M, Wang R, Harder O, Chen P, et al
    Stable attenuation of human respiratory syncytial virus for live vaccines by deletion and insertion of amino acids in the hinge region between the mRNA capping and methyltransferase domains of the large polymerase protein.
    J Virol. 2020 Sep 30. pii: JVI.01831-20. doi: 10.1128/JVI.01831.
    >> Share

  148. GMYREK GB, Filiberti A, Montgomery M, Chitrakar A, et al
    HSV-1 0DeltaNLS Live-Attenuated Vaccine Protects Against Ocular HSV-1 Infection in the Absence of Neutralizing Antibody in HSV-1 gB T Cell Receptor-Specific Transgenic Mice.
    J Virol. 2020 Sep 30. pii: JVI.01000-20. doi: 10.1128/JVI.01000.
    >> Share

  149. SCHORCHT A, van den Kerkhof TLGM, Cottrell CA, Allen JD, et al
    Neutralizing antibody responses induced by HIV-1 envelope glycoprotein SOSIP trimers derived from elite neutralizers.
    J Virol. 2020 Sep 30. pii: JVI.01214-20. doi: 10.1128/JVI.01214.
    >> Share

  150. GODI A, Boampong D, Elegunde B, Panwar K, et al
    Comprehensive Assessment of the Antigenic Impact of Human Papillomavirus Lineage Variation on Recognition by Neutralizing Monoclonal Antibodies Raised Against Lineage A Major Capsid Proteins of Vaccine-Related Genotypes.
    J Virol. 2020 Sep 23. pii: JVI.01236-20. doi: 10.1128/JVI.01236.
    >> Share

  151. CHOI JA, Goo J, Yang E, Jung DI, et al
    Cross-Protection against MERS-CoV by Prime-Boost Vaccination Using Viral Spike DNA and Protein.
    J Virol. 2020 Sep 23. pii: JVI.01176-20. doi: 10.1128/JVI.01176.
    >> Share

  152. MUSICH T, Thovarai V, Venzon DJ, Mohanram V, et al
    A prime/boost vaccine regimen alters the rectal microbiome and impacts immune responses and viremia control post-SIV infection in male and female rhesus macaques.
    J Virol. 2020 Sep 23. pii: JVI.01225-20. doi: 10.1128/JVI.01225.
    >> Share

  153. CHANDRASEKAR SS, Kingstad-Bakke B, Wu CW, Suresh M, et al
    A Novel Mucosal Adjuvant System for Immunization against Avian Coronavirus Causing Infectious Bronchitis.
    J Virol. 2020;94.
    >> Share

  154. YE C, de la Torre JC, Martinez-Sobrido L
    Development of Reverse Genetics for the Prototype New World Mammarenavirus Tacaribe Virus.
    J Virol. 2020;94.
    >> Share

  155. PIERCE BG, Keck ZY, Wang R, Lau P, et al
    Structure-based design of hepatitis C virus E2 glycoprotein improves serum binding and cross-neutralization.
    J Virol. 2020 Sep 2. pii: JVI.00704-20. doi: 10.1128/JVI.00704.
    >> Share

    August 2020
  156. THOMAS A, Thiono DJ, Kudlacek ST, Forsberg J, et al
    Dimerization of Dengue Virus E Subunits Impacts Antibody Function and Domain Focus.
    J Virol. 2020;94.
    >> Share

  157. WANG W, Liu Q, Li T, Geng T, et al
    Fiber-1, Not Fiber-2, Directly Mediates the Infection of the Pathogenic Serotype 4 Fowl Adenovirus via Its Shaft and Knob Domains.
    J Virol. 2020;94.
    >> Share

  158. XIE L, Han Y, Ma Y, Yuan M, et al
    P108 and T109 on E2 Glycoprotein Domain I Are Critical for the Adaptation of Classical Swine Fever Virus to Rabbits but Not for Virulence in Pigs.
    J Virol. 2020;94.
    >> Share

  159. WANG Y, Lv Y, Niu X, Dong J, et al
    L226Q mutation on influenza H7N9 virus hemagglutinin increases receptor-binding avidity and leads to biased antigenicity evaluation.
    J Virol. 2020 Aug 12. pii: JVI.00667-20. doi: 10.1128/JVI.00667.
    >> Share

    July 2020
  160. RESCH TK, Wang Y, Moon S, Jiang B, et al
    Serial Passaging of the Human Rotavirus CDC-9 Strain in Cell Culture Leads to Attenuation: Characterization from In Vitro and In Vivo Studies.
    J Virol. 2020;94.
    >> Share

  161. SANCHEZ-CORDON PJ, Jabbar T, Chapman D, Dixon LK, et al
    Absence of Long-Term Protection in Domestic Pigs Immunized with Attenuated African Swine Fever Virus Isolate OURT88/3 or BeninDeltaMGF Correlates with Increased Levels of Regulatory T Cells and Interleukin-10.
    J Virol. 2020;94.
    >> Share

    June 2020
  162. ZHENG A, Sun W, Xiong X, Freyn AW, et al
    Enhancing Neuraminidase Immunogenicity of Influenza A Viruses by Rewiring RNA Packaging Signals.
    J Virol. 2020 Jun 3. pii: JVI.00742-20. doi: 10.1128/JVI.00742.
    >> Share

    May 2020
  163. REDDY VRAP, Sadigh Y, Tang N, Yao Y, et al
    Novel Insights into the Roles of Bcl-2 Homolog Nr-13 (vNr-13) Encoded by Herpesvirus of Turkeys in the Virus Replication Cycle, Mitochondrial Networks, and Apoptosis Inhibition.
    J Virol. 2020;94.
    >> Share

    April 2020
  164. DU PONT V, Wirblich C, Yoon JJ, Cox RM, et al
    Identification and Characterization of a Small-Molecule Rabies Virus Entry Inhibitor.
    J Virol. 2020 Apr 22. pii: JVI.00321-20. doi: 10.1128/JVI.00321.
    >> Share

  165. SONG Y, Feng N, Sanchez-Tacuba L, Yasukawa LL, et al
    Reverse Genetics Reveals a Role of Rotavirus VP3 Phosphodiesterase Activity in Inhibiting RNase L Signaling and Contributing to Intestinal Viral Replication In Vivo.
    J Virol. 2020;94.
    >> Share

    March 2020
  166. BOON SS, Xia C, Lim JY, Chen Z, et al
    Human Papillomavirus 58 E7 T20I/G63S Variant Isolated from an East Asian Population Possesses High Oncogenicity.
    J Virol. 2020;94.
    >> Share

    February 2020
  167. DOEPKER LE, Simonich CA, Ralph D, Shipley MM, et al
    Diversity and function of maternal HIV-1-specific antibodies at the time of vertical transmission.
    J Virol. 2020 Feb 19. pii: JVI.01594-19. doi: 10.1128/JVI.01594.
    >> Share

  168. ISHII H, Terahara K, Nomura T, Takeda A, et al
    A novel immunogen selectively eliciting CD8(+) T cells but not CD4(+) T cells targeting immunodeficiency virus antigens.
    J Virol. 2020 Feb 5. pii: JVI.01876-19. doi: 10.1128/JVI.01876.
    >> Share

    January 2020
  169. SKARLUPKA AL, Reneer ZB, Abreu RB, Ross TM, et al
    An influenza HA Computationally Optimized Broadly Reactive Antigen elicits antibodies endowed with group-1 heterosubtypic breadth against swine influenza viruses.
    J Virol. 2020 Jan 29. pii: JVI.02061-19. doi: 10.1128/JVI.02061.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016